Search
Xenon Pharmaceuticals Inc
XENEAdd to Watchlist
40.850USD
-16.500-28.77%
Market hours 09/18, 10:41（ET）
3.95BMarket Cap
LossP/E TTM
Xenon Pharmaceuticals Inc (XENE) Stock Price Target & Forecast
Analyst Rating
Based on 20 analysts giving stock ratings to Xenon Pharmaceuticals Inc in the past month.
Buy
9 Strong Buy
11 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
81.294USD+44.45%
XENE Analyst Recommendation Trends
In the current month, XENE has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XENE average Analyst price target in the last month is 81.294.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
9
9
9
9
9
9
9
8
11
11
11
11
11
11
12
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
20
20
20
20
20
21
20
XENE Analyst Rating for Peer Comparison
Updated: Sep 17, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Financial Forecasting
Based on analysts' estimates, XENE EPS is projected to reach -1.137 in FY2026Q3, following reported EPS of -1.112 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.19
-1.18
-1.14
-1.14
-1.16
Actual
-1.31
-1.17
-1.11
--
--
Surprise
-10.26%
+1.10%
+2.30%
--
--
FAQs
What is Xenon Pharmaceuticals Inc's price target?
Analysts forecast that Xenon Pharmaceuticals Inc's price target is USD 81.29, with the highest forecast at USD 100.00 and the lowest forecast at USD 69.00.
How have Xenon Pharmaceuticals IncXENE's recent earnings per share performed?
The market expectation was USD -1.11, while Xenon Pharmaceuticals IncXENE's earnings per share (EPS) for the previous quarter was USD -1.17. EPS for the next quarter is expected at USD -1.14.
What is the analyst rating for Xenon Pharmaceuticals Inc?
Based on the ratings of Xenon Pharmaceuticals Inc's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.